• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Assisted Reproduction: Do Fresh Embryo Transfers Lead to Higher Birth Rates Among Women Receiving Donor Oocytes?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • There is some evidence that cryopreserved-thawed embryo transfers lead to higher live birth rates than fresh embryo transfers in IVF cycles
  • Data is limited for donor embryo transfers
  • Insogna et al. (JAMA, 2021) examined whether a fresh donor embryo transfer is more likely to result in a live birth vs cryopreserved-thawed embryo transfer

METHODS:

  • Retrospective cohort study
  • Data sources
    • The Society for Assisted Reproductive Technology (SART)
  • Participants
    • IVF recipients undergoing fresh donor oocyte cycles in the US between January 2014 and December 2017
  • Exposures (freshly retrieved donor oocytes)
    • Fresh embryo transfer
    • Cryopreserved-thawed embryo transfer
  • Study design
    • Analyses were adjusted for potential confounding: Donor age | Day of embryo transfer | Use of a gestational carrier | Assisted hatching
  • Primary outcome
    • Live birth rate
  • Secondary outcome
    • Clinical pregnancy rate
    • Miscarriage rate

RESULTS:

  • 33,863 embryo recipients underwent assisted reproduction with freshly retrieved donor oocytes
  • The following were similar between exposure groups
    • Median (IQR) age: 42.0 (37.0 to 44.0) years vs 42.0 (36.0 to 45.0) years
    • Gravidity: 1 (0 to 2) vs 1 (0 to 3)
    • Parity: 0 (0 to 1) vs 1 (0 to 1)
    • BMI: 24.5 (21.9 to 28.7) vs 24.4 (21.6 to 28.7)
  • 51,942 embryo transfer cycles
    • Fresh embryo transfer cycles: 29.5%
    • Cryopreserved-thawed embryo transfer cycles: 70.5%
  • There was no significant difference in the mean number of embryos transferred between the groups
    • Fresh: 92.4% blastocysts transferred
    • Cryopreserved-thawed: 96.5% blastocysts transferred
  • Live birth rate was higher following fresh embryo transfer vs cryopreserved-thawed embryo transfer
    • Fresh: 56.6%
    • Cryopreserved-thawed: 44.0%
    • Absolute difference 12.6% (95% CI, 11.7% to 13.5%)
    • Adjusted relative risk (aRR) 1.42 (95% CI, 1.39 to 1.46)
  • Clinical pregnancy rates were higher following fresh embryo transfer
    • Fresh: 66.7%
    • Cryopreserved-thawed: 54.2%
    • Absolute difference 12.5% (95% CI, 11.6% to 13.4%)
    • aRR 1.34 (95% CI, 1.31 to 1.37)
  • Miscarriage rates were similar between the two groups
    • Fresh: 9.3%
    • Cryopreserved-thawed: 9.4%
    • Absolute difference 0.2% (95% CI, −0.4% to 0.7%)
    • aRR 0.98 (95% CI, 0.91 to 1.07)
  • PGT-A did not impact outcomes

CONCLUSION:

  • Compared to cryopreserved-thawed embryo transfer, fresh embryo transfer led to higher birth rates and clinical pregnancy rates among women undergoing assisted reproduction using freshly retrieved donor oocytes
  • Limitations of this study include missing data from the SART database and the potential for selection and confounding bias
  • The authors note that while reporting on obstetrical outcomes was beyond the scope of this study

Use of donor oocytes independently increases the risk of preeclampsia, and whether this is in part due to the type of uterine preparation needs to be elucidated in future studies

Learn More – Primary Sources:

Association of Fresh Embryo Transfers Compared With Cryopreserved-Thawed Embryo Transfers With Live Birth Rate Among Women Undergoing Assisted Reproduction Using Freshly Retrieved Donor Oocytes

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Frozen or Fresh Embryos for IVF Transfer?
RCT Results: Fresh vs Frozen Strategy for Embryo Transfer?
Embolism Following IVF: Does Fresh or Frozen-Thawed Transfer Matter?
ACOG Addresses Preimplantation Genetic Testing

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Download Your ObG App
HERE!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site